Objective: Visceral adiposity is generally considered to play a key role in the metabolic syndrome. But not known is whether greater visceral adiposity directly measured by computed tomography (CT) is associated with increased future insulin resistance independent of other adipose depots.
lthough the pathogenesis of the metabolic syndrome and each of its components is complex and not fully understood, both insulin resistance and central obesity appear to be important. Moreover, central obesity has been reported to correlate strongly with insulin resistance (1-7). However, excess central obesity can accumulate either intraperitoneally or subcutaneously and this has led to a debate whether visceral or abdominal subcutaneous fat is more strongly associated with insulin resistance (1) (2) (3) (4) (5) (6) (7) . Some studies have reported that excess visceral fat was more strongly associated with insulin resistance than any other adipose tissue compartment (1) (2) (3) (4) (5) . Others have reported that excess abdominal subcutaneous fat was more strongly associated with insulin resistance than visceral fat (6, 7) . As these studies were all cross-sectional, conclusions about temporal sequence and cause and effect relationships cannot be made.
Although the glucose clamp is considered to be the "gold standard" test for examining insulin resistance, practical considerations limit its use in large scale epidemiologic research. Homeostasis model assessment (HOMA IR) was developed to serve as a surrogate measure of insulin resistance that only requires assessment of basal glucose and insulin concentrations (8) and it as well as fasting plasma insulin have frequently been used in epidemiological studies to assess insulin sensitivity (9) . As fasting plasma insulin and HOMA IR reflect mainly hepatic insulin resistance in the basal state, other surrogate measures have been developed to assess whole-body insulin sensitivity such as the Matsuda index derived from the oral glucose tolerance test (OGTT). This measure has been reported to be highly correlated with the rate of whole-body insulin disposal during the euglycemic insulin clamp (10) .
The purpose of this study was to determine whether greater visceral adiposity directly measured by computed tomography (CT) was associated independent of other adipose depots with a future increase in insulin resistance as assessed by multiple measures, including HOMA-IR, fasting plasma insulin, the Matsuda index, and the insulin area under the oral glucose tolerance test curve (AUC) (10) . Methods. Study population. The study population consisted of second and thirdgeneration (mean age 50.3 years) Japanese Americans enrolled in the Japanese American Community Diabetes Study who did not have type 2 diabetes both at entry and during the 10-11 year follow-up. Details about selection and recruitment have been described previously (11, 12) . Subjects were chosen from volunteers through community-wide recruitment and were representative of Japanese-American residents of King County, Washington, in age distribution, residential distribution, and parental immigration pattern. A comprehensive mailing list and telephone directory that included almost 95% of the Japanese-American population of King County, Washington, was used. All participants were of 100% Japanese ancestry. Subjects returned for follow-up examinations 5-6 and 10-11 years after a baseline evaluation.
For the current analysis, eligible subjects had a fasting plasma glucose <7.0 mmol/L and 2-h plasma glucose after a 75g oralglucose-tolerance test <11.1 mmol/L and were not taking oral hypoglycemic medications or insulin at baseline or at the 5-6 and 10-11 year examinations. We excluded 238 of the 658 subjects in the original cohort because they did not meet the above criteria. We excluded an additional 93 persons because of death, loss to follow-up, or withdrawal from the study. Another 21 persons who completed follow-up but had missing A covariate information were also excluded. The analytic cohort consisted of 306 persons. The follow-up rate in the present study was 78% (327 of 420) at the 10-to 11-year examination. Data collection. All evaluations were performed at the General Clinical Research Center, University of Washington. The protocol for this research was approved by the Human Subjects Review Committee at the University of Washington and signed informed consent was obtained from all participants. All subjects were classified as having normal glucose tolerance, impaired fasting glucose, impaired glucose tolerance, or type 2 diabetes based on a 75-gram oral glucose tolerance test after a 10 hour fast interpreted using the American Diabetes Association 1997 criteria with plasma collected at 0 minutes and at 30, 60, and 120 minutes following the glucose load (13) . Plasma glucose was assayed by an automated glucose oxidase method. Fasting plasma insulin was measured by radioimmunoassay as reported previously (14) . The proportion of insulin measured that was proinsulin was in the range of 10-15%. Insulin sensitivity was estimated by using fasting plasma insulin, HOMA IR calculated as (fasting glucose (mmol/l)) x (fasting insulin (µU/ml)) / 22.5, Matsuda index (10,000/square root of [fasting glucose (mg/dl) x fasting insulin (µU/ml)] x [mean glucose (mg/dl) x mean insulin (mg/dl) during OGTT]), and AUC for insulin (8, 10) . A modified Matsuda score was calculated due to the absence of the 90 minute post-glucose load value in our study. AUC for insulin was calculated using the trapezoidal rule. Increasing values of the insulin resistance measures indicate greater resistance, except for the Matsuda index, where the opposite is true. To assess insulin release, we used the incremental insulin response (IIR) ((30 min insulin -fasting insulin) / 30 min glucose), which correlates well with direct measures of stimulated insulin secretion (15) .
BMI was calculated as the weight in kilograms divided by the height in meters squared. Single CT scans were obtained of the thorax, abdomen, and right thigh to measure fat areas (cm 2 ) as described previously (16) . In addition to subcutaneous fat at each of these sites, visceral adiposity was measured as intra-abdominal fat area (IAFA) at the umbilicus level. This latter measurement has been reported to have a high correlation with directly ascertained total visceral fat volume by CT or magnetic resonance imaging (17, 18) . Total fat area (TFA) was calculated as the sum of IAFA, subcutaneous thorax and subcutaneous abdominal fat areas, and twice the right thigh subcutaneous fat area. In research that we have previously conducted, TFA correlates highly with fat mass as measured by hydrodensitometry among Japanese Americans (r = 0.89-0.94) (19) . Total subcutaneous fat area was defined as TFA minus IAFA. Waist circumference was measured at the level of the umbilicus to the nearest tenth centimeter. Statistical Analysis. Pearson correlation coefficients were calculated for comparisons between HOMA IR, fasting plasma insulin level, Matsuda index, or AUC of insulin at 10-11 year follow-up and measures of body fat or metabolic characteristics at baseline. Multiple linear regression analysis was used to model a future insulin resistance measure as a function of other variables, while adjusting for the baseline value of the same insulin resistance measure. To assess whether the correlation between baseline measures of regional or total adiposity and future insulin resistance measures varied significantly by gender, first-order interactions between these variables and gender were inserted into a regression model that contained the interaction term and both covariates as main effects. Analysis of residuals was performed to examine model fit and adherence to regression assumptions. The dependent variables in regression models were log transformed to satisfy the assumption of normality of residuals and to stabilize variance of residuals. Multicollinearity was assessed using the variance inflation factor (VIF) (20) . A VIF exceeding 10 is regarded as indicating serious multicollinearity, and values greater than 4.0 may be a cause for concern (20) . All P values are two-tailed. Statistical analyses were performed using Stata SE, version 10.0 (Stata Corp., College Station, Texas).
RESULTS
Baseline characteristics of the study subjects are shown in Table 1 . Study subjects on average were not obese, with a median BMI of 23.4, but 32.4%, met the obesity criterion of the Japan Society for the Study of Obesity (BMI ≥ 25.0), while only 4.2% met the non-Asian criterion (BMI > 30) (21) .
Correlation coefficients between HOMA IR or fasting plasma insulin level, Matsuda index, or AUC for insulin at 10-11 year follow-up and measures of body fat or metabolic characteristics at baseline are shown in Table 2 . All measures of regional or total adiposity at baseline were significantly correlated with future HOMA IR, fasting plasma insulin level, Matsuda index, or AUC of insulin at 10-11 year follow-up in the expected direction (negative for Matsuda index and positive otherwise).
A number of regression models were tested to assess the associations between body fat distribution and future HOMA IR (Table  3 ). IAFA at baseline was associated with an increased future HOMA IR after adjusting for age, gender, HOMA IR, IIR, 2-hour plasma glucose, and abdominal subcutaneous fat area at baseline (Model 1 of Table 3 ). Models 2-5 of Table 3 were identical to model 1, with the exception that a different adiposity variable was substituted for abdominal subcutaneous fat area. The association between baseline IAFA and future HOMA IR persisted (Model 2-5 of Table 3 ). None of the other measures of regional or total adiposity emerged as significantly related to increased future HOMA IR (Model 1-5 of Table 3 ). Baseline HOMA IR was also associated with increased future HOMA IR (Model 1 -5 of Table 3) . Age, IIR, gender, and 2-hour plasma glucose were not significant (Table 3) . Similar results were obtained for the models predicting future fasting plasma insulin level, Matsuda index, or AUC of insulin (Tables 3 and 4) . We also examined the first-order interaction terms between gender and the measures of regional or total adiposity, in the prediction of HOMA IR, fasting plasma insulin, Matsuda index, or AUC of insulin in all models of Tables 3 and 4 . None of the interactions between gender and the measures of regional or total adiposity was significant, thereby indicating that the associations between adiposity and future insulin resistance measure did not vary by gender. No evidence of multicollinearity (VIF of 4 or greater) was seen in any model in Tables 3 and 4 .
DISCUSSION
These prospective data demonstrated that baseline visceral adiposity was related to future fasting plasma insulin level, HOMA-IR, Matsuda index, and AUC of insulin. These findings were independent of baseline fasting plasma insulin level, HOMA-IR, Matsuda index, or AUC of insulin (depending on the model), age, gender, 2-hour plasma glucose level, incremental insulin response, and other measures of total and regional adiposity, such as body mass index, total subcutaneous fat area, abdominal subcutaneous fat area, or waist circumference. No other CTmeasurement of regional or total adiposity was related with future fasting plasma insulin level, HOMA-IR, Matsuda index, or AUC of insulin in models that contained IAFA.
Controversy has arisen from previous cross-sectional studies as to whether IAFA or abdominal subcutaneous fat area is more closely related to insulin resistance (1-7).
Several cross-sectional studies have reported that IAFA is the major determinant of insulin resistance (1-4). However, two other studies have suggested that abdominal subcutaneous fat area is a more important determinant of insulin resistance than IAFA (6,7). Incomplete control for confounding or biased study population selection may explain the inconclusive association. Furthermore it is not possible to draw conclusions about the temporal sequence of these associations because of the cross-sectional nature of these data. Wagenknecht et al. showed in 1457 men and women in the Insulin Resistance Atherosclerosis Study Family Study that IAFA, abdominal subcutaneous fat area, and their interaction were inversely associated with insulin sensitivity calculated by the minimal model analysis adjusted for age, body mass index, sex, and ethnicity (5). Their results were also based on cross-sectional data. To our knowledge, ours is the first prospective study to evaluate the relationship of directly measured visceral adiposity to future fasting plasma insulin level ,HOMA-IR, Matsuda index, or AUC of insulin.
We previously reported in the same population the effect of baseline fasting plasma insulin and baseline IAFA on IAFA measured after 5 and 10-11 year follow-up (22, 23) . Both baseline higher fasting plasma insulin level and greater IAFA were positively and independently correlated with IAFA at 5 years and 10-11 years (23) . In the present study we demonstrated in the same population that both baseline greater IAFA and higher fasting plasma insulin level were positively and independently correlated with longitudinal increases in insulin resistance. Taken together, our previously published and current results suggest that the development of IAFA accumulation and insulin resistance go hand-in-hand. A positive feedback loop might serve as a model for this association. It is not possible from the research that we have previously performed or describe in this paper to determine which phenomenon comes first. A study of these phenomena in young adults or children may be informative in this regard.
In the present study we did not assess mechanisms to explain the association between visceral fat and future fasting plasma insulin level, HOMA-IR, Matsuda index, or AUC of insulin. A plausible mechanism may be at least in part due to the portal theory (24) . Visceral fat has been suggested to have greater lipolytic potential than subcutaneous fat (24, 25) . This may in turn result in increased delivery of free fatty acid to the liver via the portal vein, which may produce hepatic insulin resistance by stimulating gluconeogenesis and interfering with hepatic insulin removal (26) . Although this theory has scientific appeal, few studies on the effect of lipolysis of visceral fat on the delivery of free fatty acid to the liver are available, and the contribution of lipolysis of visceral fat to extrahepatic availability of free fatty acids may be small (27) . Adipocyte-derived proteins may also play a key role in the pathogenesis of peripheral insulin resistance (28) . For instance, levels of the insulin sensitizing adipocyte-derived protein adiponectin are reported to be positively related with insulin sensitivity (29) . Interestingly, visceral fat has been reported to have a more important role in producing this peptide than subcutaneous fat and increased visceral fat is frequently associated with lower adiponectin levels (29-31). Therefore, adipocyte-derived circulating factors may be involved in part in the pathogenesis of insulin resistance associated with visceral adiposity.
There are potential limitations to our study. First, surrogate measures were used to estimate insulin resistance (HOMA-IR) and release (IIR). Any error that occurred as a result of these indirect measures, however, is likely to be random, as opposed to systematic, thereby biasing study results toward null values (32) . Therefore, significant differences probably reflect underestimates of the true effect, although no differences might be explained by this random misclassification bias or absence of a true effect. Second we used the sum of the areas of a limited number of CT scans to estimate total body fat mass. However, our group has found that this measurement correlates highly with fat mass as measured by hydrodensitometry among Japanese Americans (19) . Visceral fat volume was also estimated with a single CT scan at the umbilicus (L4-L5) level. This measurement has been reported to have a high correlation with directly ascertained total visceral fat volume (17, 18) . Third, it is not clear whether our findings might apply to other ethnic groups. Asians and Asian Americans have been reported to have a lower prevalence of obesity by BMI compared with Caucasians and have a higher percentage of body fat at the same BMI level as Caucasians (33, 34) . Whether such differences also exist with regard to relationships between adiposity and future fasting plasma insulin level, HOMA-IR, Matsuda index, or AUC of insulin by ethnicity is not known. Fourth, fasting plasma insulin and HOMA IR reflect mainly hepatic insulin resistance in the basal state. As insulin resistance in the peripheral tissues is a major component of insulin sensitivity as measured by the hyperinsulinemic euglycemic clamp, we also used the Matsuda index as a surrogate maker of insulin sensitivity because it is reported to better reflect insulin-mediated peripheral glucose uptake (9, 35) . But whether these findings apply to insulin resistance measured using the clamp or other methods is not clear from these data. Lastly we used plasma glucose and insulin values at 0, 30, 60, and 120 minutes during the OGTT to calculate the Matsuda index and AUC of insulin and did not use the 90 minute value because it was not measured at this time point. This omission may have resulted in a Matsuda index that is less strongly correlated with the gold standard measurement of insulin resistance.
In conclusion, the present study provides evidence that visceral fat is an important predictor of future fasting plasma insulin level, HOMA-IR, Matsuda index, and AUC of insulin among Japanese Americans. This association is independent of other measures of total or regional adiposity. In particular abdominal subcutaneous fat area and total subcutaneous fat area were not independently associated with future fasting plasma insulin level, HOMA-IR, Matsuda index, and AUC of insulin in multiple-adjusted models, which suggests that among all fat deposits, visceral fat has the most important role in predicting future insulin resistance. Our results suggest that a reduction in the size of the visceral fat depot may be effective in preventing future elevations of fasting plasma insulin level, HOMA-IR, Matsuda index, and AUC for insulin. Data are median (inter quartile range) or %. NGT, NFG, and IGT denote normal glucose tolerance, normal fasting glucose, and impaired glucose tolerance, respectively, which were defined as follows: IGT -fasting plasma glucose (FPG) level < 7.0 mmol/l and 2-h glucose ≥ 7.7 and < 11.1 mmol/l; IFG only -FPG level ≥ 6.1 mmol/l and < 7.0 mmol/l and 2-h glucose < 7.7 mmol/l; and NGT and NFG only -FPG level < 6.1 mmol/l and 2-h glucose < 7.7 mmol/l. AUC denotes area under the curve during the oral glucose tolerance test. Log e denotes natural logarithm. β and β' denotes regression coefficient and standardized regression coefficient, respectively. *Two-hour plasma glucose, age, and female sex were not significant in any model.
